1. You are a lead engineer in a cGMP facility that develops and delivers tissue engineering constructs for tissue regeneration. You have been asked to develop an injectable tissue engineering solution for regenerating heart tissue following myocardial infarction. Describe an injectable tissue engineering solution to regenerate the damaged heart tissue by considering the following and give a brief explanation for your choices: 1) Bioreactor for examining tissue growth and integrity

1. You are a lead engineer in a cGMP facility that develops and delivers tissue engineering constructs for tissue regeneration. You have been asked to develop an injectable tissue engineering solution for regenerating heart tissue following myocardial infarction. Describe an injectable tissue engineering solution to regenerate the damaged heart tissue by considering the following and give a brief explanation for your choices: 1) Bioreactor for examining tissue growth and integrity

Human Physiology: From Cells to Systems (MindTap Course List)

9th Edition

ISBN:9781285866932

Author:Lauralee Sherwood

Publisher:Lauralee Sherwood

Chapter10: The Blood Vessels And Blood Pressure

Section: Chapter Questions

Problem 11RE

See similar textbooks

Similar questions

Describe why a doctor would give a patient that is diagnosed with acute myocardial infarction the treatment of tissue plasminogen activator(tPA)? What will it do?
Describe the mechanism of action of cardiac glycosides, such as digitalis.
Name three mechanisms that can increase cardiacoutput.
What are the current challenges involved in the treatment of atherosclerosis at activated endothelium with conventional therapeutics, e.g., aspirin or Acebutolol?
Throughout the development of prosthetic heart valves, how might application of nanotechnology be used to improve the strength of the prosthetic heart valves and reduce complications and failures? Discuss.
Give a detailed mechanism of action of a name drug or agonist that results in positive inotropic changes in the cardiac cell.
Discuss the mechanism underlying AP generation by cardiac autorhythmic cells
The exact cause of blood clotting in the left atrium of the heart during atrial fibrillation (AF) is not known. In part it might be due to blood stasis (not moving) or it may result in combination with endothelial cells damage. (A) What are the potential mechanisms that might drive clotting and what markers might you look for in the blood to predict potential risk? (B) Other than treating the arrhythmia, what other pharmacological intervention might be provided to AF sufferers?
Explain the biochemical basis and clinical implications of atherosclerosis with molecular and mechanistic detail.
In the nineteenth century, Poiseuille’s law was experimentally deduced byJ. L. M. Poiseuille, who was interested in understanding the flow of blood inhorses’ arteries.We nowknowthat Poiseuille’s lawis a poorway of modelingblood flow in arteries. In your own words, give at least three reasons whyPoiseuille’s lawis not appropriate for arterial blood flowmodeling, and brieflydiscuss why this is the case.
All of the following are correct about the isovolumetric contraction, except ____________. A. This phase of the cardiac cycle begins with the appearance of the QRS complex of the ECG, which represents atrial repolarization and ventricular depolarization B. It represents the time period between the closure of the AV valves and the opening of the aortic and pulmonic valves, ventricular pressure rises rapidly without a change in ventricular volume C. The rate of pressure increase in the ventricles is determined by the rate of contraction of the muscle fibers, which is determine by mechanisms governing excitation-contraction coupling D. Ventricular chamber geometry changes considerably as the heart becomes more spheroid in shape; circumference increases and atrial base-to-apex length increases
In a patient given a cardiac glycoside, important effects of the drug on the heart include which of the following? a) Increased force of contraction. b)Decreased atrioventricular conduction velocity c)Decreased ejection time d)Increased ectopic automaticityAll of the above